Zolmitriptan 2.5 MG Oral Tablet — RxCUI 200193
RxNorm drug concept · Semantic clinical drug
RxCUI 200193
Semantic clinical drug · SCD
● Current RxNorm concept 25 FDA products
25 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI200193
Official nameZolmitriptan 2.5 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped25
Package NDCs mapped25
Reported Medicaid activity (SDUD)17,140 prescriptions · 41 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Zolmitriptan: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Zolmitriptan is designed to treat a migraine that's already started, not just dull the pain a little. It works on specific receptors in the brain to help narrow the widened blood v...
- What exactly does zolmitriptan do — will it stop my migraine or just take the edge off?
- Yes — if your migraine hasn't fully gone away after 2 hours, or if it comes back after initially getting better, you can take a second dose. You just need to wait at least 2 hours...
- Can I take it again if my headache comes back a few hours later?
🕸️ Concept Web — How Zolmitriptan 2.5 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Zolmitriptan 2.5 MG Oral Tablet
RxCUI 200193 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Zolmitriptan
135775IN
-
Zolmitriptan
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Zomig
153354BN
-
Zomig
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Zolmitriptan Oral Tablet
374363SCDF -
Zolmitriptan Oral Product
1156256SCDG -
Zolmitriptan Pill
1156257SCDG -
Zolmitriptan Oral Tablet [Zomig]
368302SBDF -
Zomig Oral Product
1188177SBDG -
Zomig Pill
1188178SBDG -
Oral Tablet
317541DF -
Oral Product
1151131DFG - +1 more in this family
-
Zolmitriptan Oral Tablet
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Zolmitriptan 2.5 MG
316933SCDC -
Zolmitriptan 2.5 MG Oral Tablet [Zomig]
153353SBD -
Zolmitriptan 2.5 MG [Zomig]
565245SBDC
-
Zolmitriptan 2.5 MG
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Zolmitriptan 2.5 MG
SCDC · 316933 -
Zolmitriptan Oral Tablet
SCDF · 374363 -
Zolmitriptan Oral Product
SCDG · 1156256 -
Zolmitriptan Pill
SCDG · 1156257
Brand-Name Concepts
-
Zolmitriptan 2.5 MG Oral Tablet [Zomig]
SBD · 153353 -
Zolmitriptan 2.5 MG [Zomig]
SBDC · 565245 -
Zolmitriptan Oral Tablet [Zomig]
SBDF · 368302 -
Zomig Oral Product
SBDG · 1188177 -
Zomig Pill
SBDG · 1188178 -
Zomig
BN · 153354
📦 FDA Products & Package NDCs
25 products · 25 package NDCs
25 package NDCs map to RxCUI 200193 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 16571-0803-16 | 1 BLISTER PACK in 1 CARTON (16571-803-16) / 6 TABLET, FILM... | Zolmitriptan | Rising Pharma Holdings, Inc. | 2016-05-11 |
| 16571-0804-13 | 1 BLISTER PACK in 1 CARTON (16571-804-13) / 3 TABLET, FILM... | Zolmitriptan | Rising Pharma Holdings, Inc. | 2016-05-11 |
| 27241-0021-68 | 1 BLISTER PACK in 1 CARTON (27241-021-68) / 6 TABLET in 1 B... | Zolmitriptan | Ajanta Pharma USA Inc. | 2016-05-31 |
| 27241-0022-38 | 1 BLISTER PACK in 1 CARTON (27241-022-38) / 3 TABLET in 1 B... | Zolmitriptan | Ajanta Pharma USA Inc. | 2016-05-31 |
| 46708-0462-06 | 6 TABLET, FILM COATED in 1 CARTON (46708-462-06) | Zolmitriptan | Alembic Pharmaceuticals Limited | 2016-01-04 |
| 46708-0463-03 | 3 TABLET, FILM COATED in 1 CARTON (46708-463-03) | Zolmitriptan | Alembic Pharmaceuticals Limited | 2016-01-04 |
| 60846-0130-30 | 1 BLISTER PACK in 1 CARTON (60846-130-30) / 6 TABLET, FILM... | ZOMIG | Amneal Pharmaceuticals LLC | 2023-01-09 |
| 60846-0133-60 | 1 BLISTER PACK in 1 CARTON (60846-133-60) / 3 TABLET, FILM... | ZOMIG | Amneal Pharmaceuticals LLC | 2023-01-09 |
| 62332-0462-06 | 6 TABLET, FILM COATED in 1 CARTON (62332-462-06) | Zolmitriptan | Alembic Pharmaceuticals Inc. | 2024-01-10 |
| 62332-0463-03 | 3 TABLET, FILM COATED in 1 CARTON (62332-463-03) | Zolmitriptan | Alembic Pharmaceuticals Inc. | 2024-01-10 |
| 63548-0101-06 | 1 BLISTER PACK in 1 CARTON (63548-0101-6) / 6 TABLET, FILM... | Zolmitriptan | PLD Acquisitions LLC DBA Avma Pharma Solutions | 2017-02-27 |
| 63548-0102-03 | 1 BLISTER PACK in 1 CARTON (63548-0102-3) / 3 TABLET, FILM... | Zolmitriptan | PLD Acquisitions LLC DBA Avma Pharma Solutions | 2017-02-27 |
| 65862-0914-69 | 1 BLISTER PACK in 1 CARTON (65862-914-69) / 6 TABLET, FILM... | Zolmitriptan | Aurobindo Pharma Limited | 2016-05-11 |
| 65862-0915-64 | 1 BLISTER PACK in 1 CARTON (65862-915-64) / 3 TABLET, FILM... | Zolmitriptan | Aurobindo Pharma Limited | 2016-05-11 |
| 68001-0249-01 | 1 BLISTER PACK in 1 CARTON (68001-249-01) / 6 TABLET, FILM... | Zolmitriptan | BluePoint Laboratories | 2014-03-13 |
| 68001-0250-01 | 1 BLISTER PACK in 1 CARTON (68001-250-01) / 3 TABLET, FILM... | Zolmitriptan | BluePoint Laboratories | 2014-03-13 |
| 68462-0497-76 | 1 BLISTER PACK in 1 CARTON (68462-497-76) / 6 TABLET, FILM... | Zolmitriptan | Glenmark Pharmaceuticals Inc.,USA | 2013-05-14 |
| 68462-0498-33 | 1 BLISTER PACK in 1 CARTON (68462-498-33) / 3 TABLET, FILM... | Zolmitriptan | Glenmark Pharmaceuticals Inc.,USA | 2013-05-14 |
| 69097-0863-17 | 1 BLISTER PACK in 1 CARTON (69097-863-17) / 6 TABLET, FILM... | Zolmitriptan | Cipla USA Inc. | 2016-07-20 |
| 69097-0864-84 | 1 BLISTER PACK in 1 CARTON (69097-864-84) / 3 TABLET, FILM... | Zolmitriptan | Cipla USA Inc. | 2016-07-20 |
| 71626-0101-06 | 6 BLISTER PACK in 1 CARTON (71626-101-06) / 1 TABLET, FILM... | Zolmitriptan | Medstone Pharma LLC | 2018-05-30 |
| 71626-0102-03 | 3 BLISTER PACK in 1 CARTON (71626-102-03) / 1 TABLET, FILM... | Zolmitriptan | Medstone Pharma LLC | 2018-05-30 |
| 72189-0434-06 | 6 TABLET in 1 BOTTLE (72189-434-06) | Zolmitriptan | Direct_Rx | 2023-03-13 |
| 76420-0336-06 | 1 BLISTER PACK in 1 CARTON (76420-336-06) / 6 TABLET in 1 B... | Zolmitriptan | Asclemed USA, Inc. | 2025-05-02 |
| 76420-0337-03 | 1 BLISTER PACK in 1 CARTON (76420-337-03) / 3 TABLET in 1 B... | Zolmitriptan | Asclemed USA, Inc. | 2025-05-02 |
Observed labelers:
Ajanta Pharma USA Inc. (2) ·
Alembic Pharmaceuticals Inc. (2) ·
Alembic Pharmaceuticals Limited (2) ·
Amneal Pharmaceuticals LLC (2) ·
Asclemed USA, Inc. (2) ·
Aurobindo Pharma Limited (2)
· +7 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.